コンテンツへスキップ
Merck

GN655090

Greiner CELLSTAR® microplate

96 well, TC treated, black μClear®

別名:

96 well microplate, 96 well plate, cell culture plate, treated microplate

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
41122107

包装

pack of 32 ea

メーカー/製品名

Greiner 655090

利用可能性

available only in China

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

Greiner CELLSTAR® microplates are engineered to elevate cell adhesion through advanced physical surface treatment. These microplates are characterized by high clarity and low autofluorescence, ensuring exceptional visibility and minimal interference during microscopic examinations. Moreover, these microplates enable a reduction of sample volume by up to 50%, thereby providing a significant advantage in experimental setups with sample conservation.

アプリケーション

Greiner CELLSTAR® microplate has been used to culture cancer cells, Zenbio 3T3-L1 murine pre-adipocyte cells, bone marrow-derived macrophages (BMDMs). It has also been used for testing cell viability by immunofluorescence.

特徴および利点

  • The physical surface treatment enhances cell adhesion
  • DNase, RNase, human DNA free
  • Sterile, non-cytotoxic, non-pyrogenic, and stackable
  • Alphanumeric well coding and compatible with automated systems
  • Microplates with high clarity for optimal microscopic examinations
  • The possibility of contamination from carried-over sample material is reduced.
  • Has a consistent footprint, as recommended by the American national standards institute (ANSI) (ANSI/SBS 1-2004).
  • μClear® bottom and consecutive lot numbering
  • Has a lid that permits gas exchange with minimal evaporation

法的情報

μClear is a registered trademark of Greiner Bio-One GmbH
CELLSTAR is a registered trademark of Greiner Bio-One GmbH

試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Philipp Rabe et al.
Cancer letters, 526, 91-102 (2021-11-24)
Cancer cells display metabolic alterations to meet the bioenergetic demands for their high proliferation rates. Succinate is a central metabolite of the tricarboxylic acid (TCA) cycle, but was also shown to act as an oncometabolite and to specifically activate the
Leandro Henrique de Paula Assis et al.
Frontiers in molecular biosciences, 9, 839428-839428 (2022-04-05)
Statins are successful drugs used to treat hypercholesterolemia, a primary cause of atherosclerosis. In this work, we investigated how hypercholesterolemia and pravastatin treatment impact macrophage and mitochondria functions, the key cell involved in atherogenesis. By comparing bone marrow-derived macrophages (BMDM)
Christopher D Kassotis et al.
Toxicology, 461, 152900-152900 (2021-08-20)
The 3T3-L1 murine pre-adipocyte line is an established cell culture model for screening Metabolism Disrupting Chemicals (MDCs). Despite a need to accurately identify MDCs for further evaluation, relatively little research has been performed to comprehensively evaluate reproducibility across laboratories, assess
Alberto Bresciani et al.
PloS one, 13(3), e0194423-e0194423 (2018-03-20)
Autophagy is a cellular mechanism that can generate energy for cells or clear misfolded or aggregated proteins, and upregulating this process has been proposed as a therapeutic approach for neurodegenerative diseases. Here we describe a novel set of LC3B-II and

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)